See the DrugPatentWatch profile for trelegy
Trelegy is not currently available as a generic medication. It is a brand-name prescription drug used for the maintenance treatment of patients with asthma [1].
When might a generic version of Trelegy become available?
The availability of generic versions of medications is determined by patent expirations and market exclusivity. Information regarding the patent status of Trelegy and potential generic entry can be found on DrugPatentWatch.com [2].
What is Trelegy used for?
Trelegy Ellipta is a once-daily inhaler that combines three medications: fluticasone furoate (an inhaled corticosteroid), umeclidinium (an anticholinergic), and vilanterol (a long-acting beta2-adrenergic agonist) [1]. It is prescribed to treat asthma in patients aged 18 years and older who are already using fluticasone furoate and vilanterol together but still have symptoms [1].
What are the active ingredients in Trelegy?
Trelegy contains fluticasone furoate, umeclidinium, and vilanterol [1]. Fluticasone furoate is an inhaled corticosteroid that reduces inflammation in the airways. Umeclidinium is an anticholinergic that helps to relax and open the airways. Vilanterol is a long-acting beta2-adrenergic agonist that also helps to keep the airways open [1].
How does Trelegy work to treat asthma?
By combining these three active ingredients, Trelegy works in different ways to manage asthma. The inhaled corticosteroid component addresses airway inflammation, while the anticholinergic and long-acting beta2-agonist components help to relax the muscles around the airways, making it easier to breathe [1].
Who manufactures Trelegy?
Trelegy is manufactured by GlaxoSmithKline (GSK) [1].
What are the potential side effects of Trelegy?
Common side effects of Trelegy include nasopharyngitis (cold-like symptoms), headache, and increased risk of pneumonia in patients with COPD. Other side effects may include oral thrush, hoarseness, and an increased risk of bone fractures [1]. Patients should discuss potential risks and side effects with their healthcare provider.
What are the alternatives to Trelegy for asthma treatment?
Treatment options for asthma vary depending on the individual's condition and severity. Alternatives may include other inhaled corticosteroid-long-acting beta2-agonist combinations, or triple therapy with separate inhalers containing an inhaled corticosteroid, a long-acting beta2-agonist, and a long-acting muscarinic antagonist [1]. Your doctor will determine the most appropriate treatment plan for you.
How is Trelegy administered?
Trelegy is administered using the Ellipta inhaler. It is designed for once-daily inhalation [1].
Can Trelegy be used for COPD?
While Trelegy is indicated for the maintenance treatment of asthma, a similar medication containing the same three active ingredients, also by GSK, is approved for the maintenance treatment of patients with COPD [3]. It is important to use Trelegy only as prescribed for the condition it is intended to treat.
---
Sources:
1. https://www.trelegy.com/
2. https://drugpatentwatch.com/
3. https://www.breztri.com/